Manuscripts
Showing 1595 manuscripts.
Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy.
Citation
Nathalie Ylitalo, M.D., Ph.D., Susan Brogly, Ph.D., Michael Hughes, Ph.D., Sharon Appelbaum Nachman, M.D., Wayne M. Dankner, M.D., Russell B. Van Dyke, M.D., George Seage, III, Sc.D., M.P.H. Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy. Archives of Pediatrics and Adolescent Medicine. 2006 Aug 01; 160(8):778 - 787. PMID: 16894075.Year
2006
Journal
Archives of Pediatrics and Adolescent Medicine
The Pediatric AIDS Severity Score (PASS): a multidimensional AIDS-severity adjustment for pediatric HIV infection.
Citation
George Seage, III, Sc.D., M.P.H., Kate Buchacz, Ph.D., Geoffrey A. Weinberg, M.D., Kunjal Patel, D.Sc., M.P.H., Kenneth McIntosh, M.D., Wayne M. Dankner, M.D. The Pediatric AIDS Severity Score (PASS): a multidimensional AIDS-severity adjustment for pediatric HIV infection. Journal of Acquired Immune Deficiency Syndromes. 2006 Dec 15; 43(5):603 - 610. PMID: 17003692.Year
2006
Journal
Journal of Acquired Immune Deficiency Syndromes
HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothers.
Citation
Elizabeth (Betsy) J. McFarland, M.D., Daniel Johnson, M.D., Petronella Muresan, M.S., Terence Fenton, Ed.D., Georgia D. Tomaras, Ph.D., James McNamara, M.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Steven D. Douglas, M.D., Jaime G. Deville, M.D., Marc Gurwith, M.D., Sanjay Gurunathan, M.D., John S. Lambert, M.D. HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothers. AIDS. 2006 Jul 13; 20(11):1481 - 1489.Year
2006
Journal
AIDS
Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140)
Citation
William T. Shearer, M.D., Ph.D., Jaime G. Deville, M.D., Pearl Samson, M.S., John ( Jack ) Moye, Jr., M.D., Courtney V. Fletcher, Pharm.D., Joseph A. Church, M.D., Hans ML Spiegel, M.D., Ph.D., Paul Palumbo, M.D., Terence Fenton, Ed.D., Elizabeth (Betsy) Smith, M.D., Bobbie L. Graham, B.S., William C. Olson, Ph.D. Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140). Journal of Allergy and Clinical Immunology. 2006 Aug 01; 118(2):518 - 521. PMID: 16890780.Year
2006
Journal
Journal of Allergy and Clinical Immunology
Simple Pediatric AIDS Severity Score (PASS): a pediatric severity score for resource-limited settings.
Citation
Kunjal Patel, D.Sc., M.P.H., Geoffrey A. Weinberg, M.D., Kate Buchacz, Ph.D., Kenneth McIntosh, M.D., Wayne M. Dankner, M.D., George Seage, III, Sc.D., M.P.H. Simple Pediatric AIDS Severity Score (PASS): a pediatric severity score for resource-limited settings. Journal of Acquired Immune Deficiency Syndromes. 2006 Dec 15; 43(5):611 - 617. PMID: 17003691.Year
2006
Journal
Journal of Acquired Immune Deficiency Syndromes
Neuropsychiatric complications of antiretroviral therapy
Citation
Michelle S. Cespedes, M.D., Judith A. Aberg, M.D. Neuropsychiatric complications of antiretroviral therapy. Drug Safety. 2006 Oct 01; 29(10):865-74.Year
2006
Journal
Drug Safety
Changes in the slope of the CD4 cell count increase after initiation of potent antiretroviral treatment
Citation
Ronald J. Bosch, Ph.D., Rui Wang, M.S., Florin Vaida, Ph.D., Michael M. Lederman, M.D., Mary Albrecht, M.D. Changes in the slope of the CD4 cell count increase after initiation of potent antiretroviral treatment. Journal of Acquired Immune Deficiency Syndromes. 2006 Dec 01; 43(4):433-5.Year
2006
Journal
Journal of Acquired Immune Deficiency Syndromes
Activity of newer triazoles against histoplasma capsulatum from patients with AIDS who failed fluconazole
Citation
L. Joseph Wheat, M.D., Patricia A. Connolly, M.S., Melinda L. Smedema, Michelle M. Durkin, Edward Brizendine, Paul Mann, Reena Patel, Paul McNicholas, Mitchell (Mitch) Goldman, M.D. Activity of newer triazoles against histoplasma capsulatum from patients with AIDS who failed fluconazole. Journal of Antimicrobial Chemotherapy. 2006 Jun 01; 57(6):1235-9. PMID: 16627592.Year
2006
Journal
Journal of Antimicrobial Chemotherapy
Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS clinical trials group A5138
Citation
Michael M. Lederman, M.D., Laura Smeaton, M.S., Kimberly Y. Smith, M.D., M.P.H., Benigno Rodriguez, M.D., Minya Pu, M.A., Hongying Wang, M.S., Anne Sevin, Ph.D., Pablo Tebas, M.D., Scott F. Sieg, Ph.D., Kathleen A. Medvik, B.S., M.T. (A.S.C.P.), David M. Margolis, M.D., Richard B. Pollard, M.D., Hildegund Ertl, Hernan Valdez, M.D. Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS clinical trials group A5138. Journal of Infectious Diseases. 2006 Dec 15; 194(12):1677-85.Year
2006
Journal
Journal of Infectious Diseases
Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy
Citation
David Alain Wohl, M.D., Grace McComsey, M.D., Pablo Tebas, M.D., Todd T. Brown, M.D., Marshall Jay Glesby, M.D., Ph.D., Dominic N. Reeds, M.D., Cecilia M. Shikuma, M.D., Kathleen Mulligan, Ph.D., Michael P. Dube, M.D., David A. Wininger, M.D., Jeannie S. Huang, M.D., M.P.H., Manuel Revuelta, M.D., Judith Silverstein Currier, M.D., M.Sc., Susan Swindells, M.B.B.S., Carl J. Fichtenbaum, M.D., Michael T. Basar, B.S., Marisa T. Tungsiripat, M.D., William A. Meyer, III, Ph.D., James Weihe, M.D., Christine Wanke, M.D. Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy. Clinical Infectious Diseases. 2006 Sep 01; 43(5):645-53.Year
2006
Journal
Clinical Infectious Diseases